“…LINE-1 hypomethylation is one of the most common epigenetic changes in cancer including HNSCC (Chalitchagorn et al, 2004;Smith, Mydlarz, Mithani, & Califano, 2007). Because circulating tumor DNA and cells can be in a mixture of sera or circulating cells, several studies reported LINE-1 methylation levels in circulating cells and sera to see its potential as tumor markers (Kitkumthorn, Keelawat, Rattanatanyong, & Mutirangura, 2012;Kitkumthorn, Tuangsintanakul, Rattanatanyong, Tiwawech, & Mutirangura, 2012;Pobsook, Subbalekha, Sannikorn, & Mutirangura, 2011;Schwarzenbach, Hoon, & Pantel, 2011;Widschwendter & Menon, 2006). However, our previous study suggested that LINE-1 methylation changes in circulation may include LINE-1 methylation changes in white blood cells (WBCs).…”